Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer. (Q39200185)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Jin Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xin-Yang Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xiao-Hui Ling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Zhuo-Yuan Lin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xin Fu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Ye-Han Deng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Hui-Chan He

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

1 reference

3 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

Integrative analysis of genomic aberrations associated with prostate cancer progression

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Molecular markers of prostate cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

A novel tumorigenic human prostate epithelial cell line (M2205): molecular cytogenetic characterization demonstrates C-MYC amplification and jumping translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

8q24 allelic imbalance and MYC gene copy number in primary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Evaluation of the 8q24 prostate cancer risk locus and MYC expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

21 January 2018

MYC and Prostate Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Distinct cellular factors regulate the c-myb promoter through its E2F element

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Sibling rivalry in the E2F family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0465-3

Expression of CD147 is associated with prostate cancer progression

21 January 2018

1 reference

12 December 2020

Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis

1 reference

12 December 2020

Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors

1 reference

12 December 2020

Chromosomal changes in incidental prostatic carcinomas detected by comparative genomic hybridization

1 reference

12 December 2020

Smad about E2F. TGFbeta repressionof c-Myc via a Smad3/E2F/p107 complex

1 reference

12 December 2020

10.1007/S12032-013-0465-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23377984%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference